Rooibos Tea: Research into Antioxidant and Antimutagenic Properties

Rooibos Tea: Research into Antioxidant and Antimutagenic Properties

**Rooibos tea**, a caffeine-free herbal infusion from South Africa, is gaining popularity for its rich **antioxidant content** and potential health benefits. Known as "red tea," this vibrant beverage offers a mild, sweet flavor and may protect against cancer, heart disease, and stroke. This article explores the science behind rooibos tea and its unique properties.


What is Rooibos Tea?

Rooibos (*Aspalathus linearis*), a shrubby legume native to South Africa’s Western Cape, is used to make a **caffeine-free, low-tannin tea** packed with **polyphenol antioxidants**. Traditionally brewed by indigenous communities, rooibos is now cultivated commercially and exported globally. Its vibrant red color (fermented) or tan/yellow hue (unfermented) distinguishes it from black or green teas made from *Camellia sinensis*.

**Rooibos tea**, also called **red tea**, is naturally caffeine-free and low in tannins, making it a gentle, antioxidant-rich alternative to traditional teas.
---

Botanical Profile of Rooibos

Rooibos grows in the nutrient-poor, acidic soils of the Cedarberg mountains. The commercially cultivated Red (Rocklands) type reaches up to 1.5 m, with needle-like leaves and yellow flowers. Its deep taproot and nitrogen-fixing bacteria allow it to thrive in harsh conditions. Genetic and chemical variations exist among wild rooibos populations, with some adapted for reseeding and others for resprouting after wildfires.

Source: Van der Bank M, et al. Biochem Syst Ecol, 1995.

---

Historical and Commercial Context

Indigenous Khoi people brewed rooibos tea over 300 years ago, a practice documented by botanists in 1772. Commercial cultivation began in the 1930s, with exports growing significantly since the 1990s. Companies like Rooibos Ltd. and organizations like ASNAPP support sustainable farming, ensuring quality through strict phytosanitary standards.

Source: WESGRO, The Rooibos Industry in the Western Cape, 2001.

---

Harvesting and Processing

Rooibos is harvested in summer, cut to 30 cm, and processed as either **fermented (red tea)** or **unfermented (green rooibos)**. Fermentation, involving bruising and sun-drying, enhances flavor but reduces antioxidant levels. Unfermented rooibos retains higher polyphenols, appealing to health-conscious consumers.

Source: Joubert E, Food Chem, 1996.

---

Antioxidant Power of Rooibos

Rooibos contains potent **polyphenol antioxidants**, including flavonoids (aspalathin, nothofagin, quercetin, rutin) and phenolic acids (caffeic acid, ferulic acid). Aspalathin, unique to rooibos, and nothofagin are abundant in unfermented tea but diminish during fermentation. A 150 ml serving of fermented rooibos (2.5 g leaves) contains about 3 mg aspalathin, 1 mg nothofagin, 2.5 mg orientin, and 3.2 mg rutin.

Rooibos Flavonoid Content (per 150 ml serving)

Flavonoid Amount (mg)
Aspalathin 3.0
Nothofagin ~1.0
Orientin 2.5
Rutin 3.2
Quercetin 0.27

Source: Bramati L, et al. J Agric Food Chem, 2002.

While rooibos has fewer total polyphenols (60-80 mg per 150-200 ml) than black tea (128-199 mg per 200 ml), its unique antioxidants, like aspalathin, show strong free radical scavenging in vitro, comparable to quercetin.

Source: Von Gadow A, et al. J Agric Food Chem, 1997.

---

Health Benefits: What the Research Says

Laboratory studies suggest rooibos’ antioxidants may offer protective effects:

  • **Cancer Protection:** Fermented rooibos reduced mutagen-induced cell damage in vitro and in mice, with unfermented rooibos showing stronger antimutagenic effects against certain mutagens.
  • **Brain Health:** Rats drinking rooibos tea for 21 months showed reduced age-related lipid peroxidation in brain regions, potentially protecting against neuronal damage.
  • **Radiation Protection:** Fermented rooibos reduced cell transformations in irradiated mouse cells and protected live mice from radiation damage.

Sources: Sasaki YF, et al. Mutat Res, 1993; Inanami O, et al. Neurosci Lett, 1995.

Caution: While animal and in vitro studies are promising, no human studies confirm rooibos’ health benefits. More research is needed to validate claims.
---

Other Claimed Benefits

Rooibos is promoted for relieving colic, allergies, digestive issues, and skin conditions, but these claims lack scientific backing. Anecdotal evidence, like Annekie Theron’s 1968 discovery of rooibos easing infant colic, drives some recommendations, but formal studies are absent.

Rooibos’ **zero caffeine and low tannin (4.4%) content** make it a gentle alternative to green or black tea, suitable for high consumption without digestive irritation. Its low tannin may also reduce iron absorption interference compared to traditional teas, though further studies are needed.

Source: Hesseling PB, et al. S Afr Med J, 1979.

---

Conclusion

Rooibos tea is a safe, caffeine-free beverage with a rich antioxidant profile, offering potential protection against free radical damage. While in vitro and animal studies suggest benefits for cancer prevention and brain health, human studies are needed to confirm these effects. Choose unfermented rooibos for higher antioxidant content or fermented for a sweeter flavor. For quality rooibos, explore products from Rooibos Ltd. or other certified suppliers.

References:

  1. Van der Bank M, et al. Biochem Syst Ecol, 1995;23(3):257-262.
  2. Dahlgren R. Bot Notiser, 1968;121:165-208.
  3. Dahlgren R. Flora of Southern Africa, 1988;16(3,6):1-430.
  4. Rooibos Limited website: www.rooibosltd.co.za.
  5. Red Bush Tea website: www.redbushtea.com.
  6. Van Wyk B-E, et al. Medicinal Plants of South Africa, 1998.
  7. Van der Bank M, et al. Plant Syst Evol, 1999;219(1,2):27-38.
  8. Muofhe ML, Dakora FD. Plant and Soil, 1999;209(2):181-6.
  9. Van Wyk B-E. Presentation, South African Association of Botanists, 2002.
  10. WESGRO, The Rooibos Industry in the Western Cape, 2001.
  11. Renaud E. Personal communication, ASNAPP, Rutgers University, 2002.
  12. Pietta PG. J Nat Prod, 2000;63(7):1035-42.
  13. Joseph J, et al. The Color Code, 2002.
  14. Rabe C, et al. Phytochem, 1994;35:1559-65.
  15. Koeppen BH, Roux DG. Biochem J, 1966;99:604-9.
  16. Koeppen BH, Roux DG. Biochem J, 1965;97:444-8.
  17. Koeppen BH, et al. Biochem J, 1962;83:507-11.
  18. Ferreira D, et al. Proceeding of Recent Development of Technologies on Fundamental Foods for Health, 1995:73-88.
  19. Bramati L, et al. J Agric Food Chem, 2002;50(20):5513-9.
  20. Joubert E. Food Chem, 1996;55(4):403-11.
  21. Von Gadow A, et al. J Agric Food Chem, 1997;45:632-38.
  22. Joubert E. Personal communication, 2002.
  23. Hakim IA, et al. Cancer Epidem Bio & Prev, 2001;10:667-78.
  24. Lee LT, et al. Anticancer Res, 2002;22(3):1615-27.
  25. Mouria M, et al. Int J Cancer, 2002;98(5):761-9.
  26. Yamashita N, Kawanishi S. Free Radic Res, 2000;33(5):623-33.
  27. RoyChowdhury A, et al. Biochem J, 2002;366(Pt 2):653-61.
  28. Yin F, et al. Thyroid, 1999;9(4):369-76.
  29. Mori H, et al. Mutat Res, 2001;480-481:201-7.
  30. Mutoh M, et al. Carcinogenesis, 2000;21(5):959-63.
  31. Mutoh M, et al. Jpn J Cancer Res, 2000;91(7):686-91.
  32. Rifici VA, et al. J Nutr, 2002;132(9):2532-7.
  33. Hirano R, et al. J Nutr Sci Vitaminol, 2001;47(5):357-62.
  34. Shimoi K, et al. Mutat Res, 1996;350(1):153-61.
  35. Hertog MG, et al. J Agric Food Chem, 1993;41:1242-6.
  36. Snyckers FO, Salemi G. JSA Chem Inst, 1974;27:5-7.
  37. Hillis WE, Inoue T. Phytochem, 1967;6:59-67.
  38. Vrinda B, Uma Devi P. Mutat Res, 2001;498(1-2):39-46.
  39. Uma Devi P, et al. Radiat Res, 1999;151(1):74-8.
  40. Uma Devi P, et al. Radiat Res, 2000;154(4):455-60.
  41. Cesarone MR, et al. J Cardiovasc Pharmacol Ther, 2002;7 Suppl 1:S17-20.
  42. MacLennan WJ, et al. Gerontology, 1994;40(1):45-52.
  43. Gouny AM, et al. J Mal Vasc, 1999;24(3):214-20.
  44. Titapant V, et al. J Med Assoc Thai, 2001;84(10):1395-400.
  45. Nocker W, et al. Vasa, 1989;18(3):235-8.
  46. Cataldo A, et al. Minerva Cardioangiol, 2001;49(2):159-63.
  47. Von Gadow A, et al. Food Chem, 1997;60(1):73-7.
  48. Sasaki YF, et al. Mutat Res, 1993;286(2):221-32.
  49. Komatsu K, et al. Cancer Lett, 1994;77(1):33-8.
  50. Inanami O, et al. Neurosci Lett, 1995;196(1-2):85-8.
  51. Marnewick JL, et al. Mutat Res, 2000;471(1-2):157-66.
  52. Standley L, et al. J Agric Food Chem, 2001;49(1):114-7.
  53. Marnewick JL. Personal communication, 2002.
  54. Eberhardt MV, et al. Nature, 2000;405(6789):903-4.
  55. Hadley CW, et al. Exp Biol Med, 2002;227(10):869-80.
  56. Stoner JD, et al. Toxicol Sci, 1999;52(2 Suppl):95-100.
  57. Santana-Rios G, et al. Mutat Res, 2001;495(1-2):61-74.
  58. Micozzi MS. Personal communication, 2003.
  59. Morton JF. Econ Bot, 1983;37(2):164-73.
  60. Kunishiro K, et al. Biosci Biotechnol Biochem, 2001;65(10):2137-45.
  61. Nakano M, et al. Biosci Biotechnol Biochem, 1997;61(2):267-71.
  62. Hurrell RF, et al. Br J Nutr, 1999;81(4):289-95.
  63. Disler PB, et al. S Afr J Med Sci, 1975;40(4):109-16.
  64. Samman S, et al. Am J Clin Nutr, 2001;73(3):607-12.
  65. Hallberg L, Rossander L. Hum Nutr Appl Nutr, 1982;36(2):116-23.
  66. Zijp IM, et al. Crit Rev Food Sci Nutr, 2000;40(5):371-98.
  67. Chung KT, et al. Crit Rev Food Sci Nutr, 1998;38(6):421-64.
  68. Bravo L. Nutr Rev, 1998;56(11):317-33.
  69. Butler LG. Basic Life Sci, 1992;59:698-8.
  70. Zeyuan D, et al. Biol Trace Elem Res, 1998;65(1):75-86.
  71. Hesseling PB, et al. S Afr Med J, 1979;55(16):631-2.
Back to blog